Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects

References

• DeAngelisAM, MartiniAE, OwenCM. Assisted reproductive technology and epigenetics. Semin Reprod Med. 2018;36:221–232. doi:10.1055/s-0038-167578030866009
   PubMed Web of Science ®Google Scholar
• ZhangY, WuQF. The clinical research and development of human assisted reproductive technology. J Int Reprod Health Fam Plan. 2012;31(2):108–114.
   Google Scholar
• Trinchard-LuganI, KhanA, PorchetHC, MunafoA. Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reprod Biomed Online. 2002;4(2):106–115. doi:10.1016/S1472-6483(10)61927-X12470572
   PubMedGoogle Scholar
• van der MerweR, LuganI, LecuelleH, PapasouliotisO, BuraglioM. The bioequivalence of liquid and freeze-dried formulations of recombinant human chorionic gonadotrophin. Curr Med Res Opin. 2004;20(3):397–402. doi:10.1185/03007990412500304415025848
   PubMed Web of Science ®Google Scholar
• WuH, LustbaderJW, LiuY, CanfieldRE, HendricksonWA. Structure of human chorionic gonadotropin at 2.6 a resolution from MAD analysis of the selenomethionyl protein. Structure. 1994;2(6):545–558. doi:10.1016/S0969-2126(00)00054-X7922031
   PubMed Web of Science ®Google Scholar
• The U.S. Multicenter Study 7927 Investigator Group, ChangP, KenleyS, BurnsT, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization–embryo transfer. Fertil Steril. 2001;76(1):67–74. doi:10.1016/s0015-0282(01)01851-9.11438321
   PubMed Web of Science ®Google Scholar
• FournierT, GuibourdencheJ, Evain-BrionD. Review: hCGs: different sources of production, different glycoforms and functions. Placenta. 2015;36:S60–65. doi:10.1016/j.placenta.2015.02.00225707740
   PubMed Web of Science ®Google Scholar
• RyanRJ, CharlesworthMC, McCormickDJ, MiliusRP, KeutmannHT. The glycoprotein hormones: recent studies of structure-function relationships. FASEB J. 1988;2(11):2661–2669. doi:10.1096/fasebj.2.11.24562422456242
   PubMed Web of Science ®Google Scholar
• LudwigM, DoodyKJ, DoodyKM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril. 2003;79(5):1051–1059. doi:10.1016/S0015-0282(03)00173-012738494
   PubMed Web of Science ®Google Scholar
• ThennatiR, SinghSK, NageN, et al. Analytical characterization of recombinant hcg and comparative studies with reference product. Biologics. 2018;12:23–35. doi:10.2147/BTT.S14120329430170
   PubMed Web of Science ®Google Scholar
• Ovidrel®. PreFilled Syringe (Choriogonadotropin Alfa Injection) [Prescribing Information]. Rockland: EMD Serono, Inc; 2018.
   Google Scholar
• HuguesJN. Comparative use of urinary and recombinant human chorionic gonadotropins in women. Treat Endocrinol. 2004;3(6):371–379. doi:10.2165/00024677-200403060-0000515511131
   PubMedGoogle Scholar
• Zegers-HochschildF, FernándezE, MackennaA, FabresC, AltieriE, LopezT. The empty follicle syndrome: a pharmaceutical industry syndrome. Hum Reprod. 1995;10(9):2262–2265. doi:10.1093/oxfordjournals.humrep.a1362818530648
   PubMed Web of Science ®Google Scholar
• MorseJH, LustbaderJW, HarringtonJW, CanfieldRE. Heterogeneity of proteins in commercial preparations of Human Chorionic Gonadotropin (hCG) demonstrated by western blotting. Am J Reprod Immunol Microbiol. 1988;17:134–140. doi:10.1111/j.1600-0897.1988.tb00217.x3202237
   PubMed Web of Science ®Google Scholar
• BassettR, De BellisC, ChiacchiariniL, et al. Comparative characterisation of a commercial human chorionic gonadotrophin extracted from human urine with a commercial recombinant human chorionic gonadotrophin. Curr Med Res Opin. 2005;21(12):1969–1976. doi:10.1185/030079905X7500516368048
   PubMed Web of Science ®Google Scholar
• ChanCC, NgEH, TangOS, YeungWS, LauEY, HoPC. A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase. J Clin Endocrinol Metab. 2005;90(7):3933–3938. doi:10.1210/jc.2004-216915870129
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline on similar biological medicinal products containing monoclonal antibodies [Draft]. 2010 Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-similar-biological-medicinal-products-containing-monoclonal-antibodies_en.pdf. Accessed 123, 2019.
   Google Scholar
• China Food and Drug Administration. Guideline for the study of bioavailability and bioequivalence of chemicals in human body. 2005 Available from: http://samr.cfda.gov.cn/directory/web/WS01/images/u6Rp9KpzuWxrzByMvM5cn6zuA+9PDtsi6zcn6zu+1yNCn0NTR0L6vLzK9da4tbzUrdTyLnBkZg==.pdf. Accessed 123, 2019.
   Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine. Guideline for industry bioequivalence: blood level bioequivalence study. 2016 Available from: https://www.fda.gov/media/89840/download. Accessed 123, 2019.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised guideline. Integrated Addendum to ICH E6(R1): guideline for Good Clinical Practice E6 (R2). 2016 Available from: https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf. Accessed 123, 2019.
   Google Scholar
• ChaYJ, KimKA, OhTY, ParkJY. Pharmacokinetics and safety profile of DA-3803, a proposed biosimilar of recombinant human chorionic gonadotropin, in healthy subjects. BioDrugs. 2015;29(3):199–205. doi:10.1007/s40259-015-0128-325998212
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.28105324141714
   PubMed Web of Science ®Google Scholar
• SchuirmannDJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15(6):657–680. doi:10.1007/BF010684193450848
   PubMedGoogle Scholar
• BagchusW, WolnaP, UhlW. Single-dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women. Reprod Med Biol. 2018;17(1):52–58. doi:10.1002/rmb2.1206629371821
   PubMed Web of Science ®Google Scholar